| Ischemic | Hemorrhagic | Not identified | P-value |
---|---|---|---|---|
No (%) | 29(52%) | 19 (34%) | 8(14%) | Â |
Age | 60.5 ± 12 | 60 ± 11 | 67 ± 15 | 0.41 |
Gender Female | 10(34.5) | 2(10.5) | 2(25) | 0.17 |
Diabetes Mellitus | 16(52.2) | 7(36.8) | 1(12.5) | 0.08 |
Hypertension | 20(69) | 9(47.4) | 6(75) | 0.23 |
Atrial fibrillation | 4(13.8) | 0(0) | 0(0) | 0.14 |
Heart rate | 92 ± 19 | 89.9 ± 15 | 83 ± 30 | 0.54 |
Systolic blood pressure | 132 ± 30 | 139 ± 35 | 116 ± 50 | 0.29 |
Diastolic blood pressure | 76 ± 24 | 84 ± 19 | 68 ± 32 | 0.28 |
STEMI | 20(69) | 16(84.2) | 4(50) | Â |
NSTEMI | 6(20.7) | 1(5.3) | 3(37.5) | Â |
UA | 3(0.3) | 2(10.5) | 1(12.5) | 0.34 |
Coronary Angiogram | 5(17.2) | 1(5.3) | 1(12.5) | 0.30 |
PCI | 2(6.9) | 1(5.3) | 0(0) | 0.47 |
Medications on admission | Â | Â | Â | Â |
Thrombolytic therapy | 10(52.6) | 5(31.2) | 0(0) | 0.11 |
Glycoprotein IIb/III inhibitors | 12(41.4) | 7(36.8) | 6(75) | 0.17 |
aspirin | 26(89.7) | 17(89.5) | 8(100) | 0.63 |
Clopidogrel | 15(51.7) | 6(31.6) | 4(50) | 0.37 |